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A B S T R A C T
Purpose: To study neuropsychological functions in children with idiopathic epilepsy at onset of
treatment and after 1 year of therapy and to identify factors associated with cognitive impairment.
Methods: 43 Subjects aged 5.2–16.9 years with newly diagnosed idiopathic epilepsy were enrolled and
started treatment with valproate or carbamazepine. At admission and after 12 months, all patients
underwent clinical examinations, the Child Behavioural Checklist, EEG and a neuropsychological test
battery. The results of each test were correlated to demographic, clinical, electrophysiological and
therapeutic variables.
Results: Except for attention, all neuropsychological functions were normal at admission and after 12
months. An improvement with time was noted for memory (p < 0.05) and logical-executive functions
(p < 0.01). Attentive deﬁcit was worse at 12 months (53.5% vs. 32.6%). Low socio-economic level and
emotional and behavioural disturbances were the only factors negatively correlated to intelligence,
memory and attention. Compared to valproate, carbamazepine was most commonly implicated.
Discussion: Idiopathic epilepsy can affect attention, even before starting treatment. Emotional and
behavioural difﬁculties and a low socio-economical status are associated with cognitive impairment.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy has been found to affect the development of cognitive
and learning functions through a number of factors: etiology,1 age
of onset,2–4 seizure type, duration and severity, interictal
epileptiform discharges,5–9 drug treatment,2,10 hereditary and
psychosocial factors.1,11,12 Epilepsy may also induce psychopatho-
logical disorders or changes in emotional and/or behavioural
responses which affect learning functions.13–16
For these reasons, newly diagnosed idiopathic epilepsies are the
best conditions to investigate the neuropsychological correlates
with the disease as there is no underlying brain lesion nor mental
retardation.17 To date, a small number of reports have studied
neuropsychological functions in children with new-onset epilep-
sy.5,18–21 Based on the results of these studies, the degree to which
cognitive impairment is present at seizure onset and the factors* Corresponding author at: Istituto di Ricerche Farmacologiche ‘‘Mario Negri’’, Via
G. la Masa 19, 20156 Milano, Italy. Tel.: +39 02 39014542; fax: +39 02 39001916.
E-mail address: beghi@marionegri.it (E. Beghi).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.07.014that may worsen intellectual abilities over time, remain to be
determined. Dissimilar ﬁndings across studies tend to reﬂect, at
least in part, a number of methodological problems such as the
inclusion of non-consecutive patients with prevalent epilepsy seen
in secondary and tertiary centers, the variable age ranges, the
assorted epilepsy characteristics, the differing latencies between
diagnosis and neuropsychological testing, and the use of different
and sometimes non-comprehensive or non-speciﬁc neuropsycho-
logical instruments.22 Therefore, when studying cognitive func-
tion, it is important tominimize these confounding factors and use
a uniform, validated and speciﬁc battery of neuropsychological
tests, including only previously untreated patients receiving
monotherapy.23
With these considerations inmind, we carried out a prospective
multicenter non-randomized study in a pediatric population
affected by generalized or partial idiopathic epilepsy, aiming to
describe the neuropsychological proﬁle at diagnosis and after 12
months of treatment.
A second speciﬁc issue of interest was to identify prognostic
factors (clinical, electrophysiological, therapeutic, social and
educational) for neuropsychological outcome.vier Ltd. All rights reserved.
[(Fig._1)TD$FIG]
Fig. 1. Study ﬂow-chart. CBCL, Child Behavioural Checklist.
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Over a 2-year period, we recruited 43 children and adolescents
(mean age 10.4 years; range 5.2–16.9; standard deviation, SD 3.1)
with idiopathic generalized or partial epilepsy. The study
population included 21 boys (48.8%; mean age 10.5 years; range
6.2–16.1; SD 2.8) and 22 girls (51.2%; mean age 10.2 years; range:
5.2–16.9; SD 3.4) consecutively referred for a ﬁrst consultation to
the Child Neuropsychiatry Units of the University of Insubria,
Macchi Foundation Hospital, Varese, to the ‘‘Eugenio Medea’’
Scientiﬁc Institute, Bosisio Parini and to the Fatebenefratelli and
Ophthalmic Hospital, Milano. According to the Italian Health
Service organization, these institutes are tertiary referral centers
receiving patients with epilepsy and offering clinical, instrumental
and genetic services. In Italy, tertiary centers are health care
facilities where a comprehensive diagnostic and therapeutic
approach is offered to patients with epilepsy who may have
access through the emergency room, from territorial pediatric
facilities, or after voluntary request.
Inclusion criteria were: (a) age between 5 and 17 years, (b)
normal pre-perinatal history, (c) normal psychomotor and
linguistic development before the onset of epilepsy, (d) normal
neurological examination, (e) seizure onset after 3 years of age.
Exclusion criteria were: (a) severe behavioural or psychiatric
disorders, (b) intelligence quotient < 70, and (c) abnormal
magnetic resonance imaging (MRI) or computerized tomography
(CT) ﬁndings (where available).
The diagnosis of epilepsy was made according to the 2001
proposed criteria of the International League Against Epilepsy.24 A
detailed clinical history was collected regarding pregnancy, birth,
psychomotor and linguistic development, clinical characteristics of
epilepsy (age at onset, type, frequency and duration), a family
history of seizures, and the parents’ social and educational level.
Data about the parents’ educational background and occupa-
tion were collected for an analysis of the socio-economic status.
Educational level was classiﬁed as: low (<8 school years), medium
(8–13 school years) and high (>13 school years). The socio-
economic level was calculated based on the cultural level and the
current occupation of both parents. The Hollingshead Index of
social position was calculated.25 Accordingly, the socio-economic
level was classiﬁed as low (Hollingshead lower-middle or lower),
medium or high (Hollingshead upper-middle or upper). Data on
school difﬁculties of the children were obtained by clinical
interviews with the parents and in selected cases by telephone
interviews with the teachers.
All the children included in the study underwent a neurological
examination, clinical interviews and EEG recordings at study entry
(T0) and then at 1, 4, and 8months. EEG during sleep,MRI or CTwas
performed where clinically indicated. The neuropsychologicalfunctionswere evaluated as soon as possible after diagnosis (within
1–4 weeks) and before the antiepileptic treatment was started (T0)
using a standardized battery of cognitive tests. The choice of drug
was decided by the caring physician according to individual clinical
and electroencephalographic features. The titration was gradually
performed adding a quarter of dose every ﬁve days until the
maximum dosage of 25 mg/kg/die (valproate) and 20 mg/kg/die
(carbamazepine) was reached. The same standardized battery of
neuropsychological tests was repeated in all patients after 12
months of therapy (T1). All patientswere still onmonoteraphy at T1.
The design of the study is summarized in Fig. 1.
The following demographic, clinical and therapeutic data were
collected: epilepsy syndrome (idiopathic partial or generalized),
age at seizure onset (before or after age ten), seizure type (partial,
generalized or secondarily generalized), seizure frequency (daily,
weekly, monthly or yearly); duration of active epilepsy (6
months or >6 months), interictal EEG abnormalities (yes/no), type
of drug (valproate or carbamazepine), behavioural–emotional
aspects and family socio-cultural level.
The study was approved by the hospitals’ Ethics Committees
and the parents of the enrolled children gave their informed
consent.
2.1. Neuropsychological assessment
The neuropsychological battery included clinical and comput-
erized tests standardized for children and adolescents aged 5
through 17 years, to assess the following functions:
2.1.1. Intelligence
The Wechsler Intelligence Scales were used to measure the
children’s general intellectual level (full IQ). These scales are
universally used for the evaluation of verbal IQ (5 sub-scales) and
non-verbal or performance IQ (5 sub-scales).26 We used theWPPSI
scale for children aged 5–6 years and theWISC-R scale for children
older than 6 years.
2.1.2. Attention skills
Evaluated by the Conners’ Continuous Performance Test, CPT,
which is a computerized test requiring the patient to press the
space bar of the computer keyboard every time a letter (target)
appears on the screen, except when the letter X (non-target)
appears. Alertness/arousal, selective attention, reaction time and
sustained attention are evaluated.27 According to the manual,28
abnormal scores (T-scores) are required on at least 2 sub-items in
order to reveal attention difﬁculties. In the present study we
considered nine main sub-scales (Hits, Commission, Hit Reaction
Time, Hit Reaction Time ST E, Variability SEs, Attentiveness, Risk
Taking, Reaction Time block change, Reaction Time ISI change) and
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least 4 sub-items27 to identify children with attention difﬁculties.
T-scores are abnormal if >90, except for sub-scales Hit RT% and
Risk Taking% in which T-scores are abnormal if <10 or >90. To
minimize the number of evaluable variables, we collapsed the nine
continuous variables into two dichotomic classes: normal (3 or less
abnormal T-scores) and abnormal (4 or more abnormal T-scores).
2.1.3. Verbal and non-verbal memory abilities
Evaluated by the TEMA test that is composed of standardised
sub-scales, enabling an assessment of verbal (5 sub-tests) and non-
verbal (5 sub-tests) memory, an index of full memory and a
delayed memory measure.29 The TEMA test explores several
memory functions of clinical and theoretical interest in children
and adolescents. The delayed memory index is a measure of the
ability to retrieve acquired information and is a sensitive indicator
of combined frontal and temporal dysfunction.
2.1.4. Associative-logical functions and problem solving
Assessed by the Wisconsin Card Sorting Test, WCST, which
consists of four stimulus cards and 128 response cards that depict
ﬁgures of varying forms, colors and numbers of ﬁgures.30 The
patient is instructed tomatch each consecutive response card with
one of the four stimulus cards, whichever card he or she thinks it
matches. The patient is told only whether each response is right or
wrong and is never told the correct sorting principle (or category).
Once the patient has made a speciﬁed number of consecutive
‘‘correct’’ matches to the initial sorting principle, the sorting
principle is changed, without warning, requiring the patient to use
the examiner’s feedback to develop a new sorting strategy.
TheWCSTwas originally developed to assess abstract reasoning
ability and the ability to shift cognitive strategies in response to
changing environmental contingencies.31 As such, theWCST can be
considered a measure of ‘‘executive function’’ and requires
strategic planning, organized searching, utilizing environmental
feedback to shift cognitive sets, directing behaviour toward
achieving a goal and modulating impulsive responding.32 Interest
in the cognitive and developmental effects of early frontal lobe
injury among children has also sparked considerable interest in the
use of WCST as a potential measure of executive function among
school-age children.33 Percentage values of errors, perseveration
and conceptual level were used.
As indicated in the manual, these standardized tests can be
repeated after 12 months without being affected by practice or
retention.
2.2. Behavioural and emotional assessment
The behavioural and emotional aspects were assessed by the
Italian version of the Child Behaviour Checklist (CBCL) for ages 4–
18 years.34 Achenbach’s CBCL is widely employed for the
assessment of adaptive behaviour and emotional problems in
the developmental age. Its reliability and validity are corroborated
by several studies carried out in both Western and Eastern
countries,35,36 and the psychometric properties of the Italian
version have been found to be comparable to Achenbach’s ﬁndings
in U.S. samples.34,37 The CBCL is a checklist to be completed by
parents and includes 118 items that are scored on a 3-point Likert
scale (0 = ‘‘not true; 1 = ‘‘somewhat or sometimes true’’; 2 = ‘‘very
true or often true’’) and referred to the preceding 6months of life of
their child. These items cover eight syndrome scales that, although
not directly equivalent to any clinical diagnosis, have proven to be
useful for screening children with behavioural and emotional
problems across multiple cultures.35,36 In our study, the Total
Problems score, whichwas obtained by the sumof the responses to
all items, has been used to identify children with behavioural andemotional disorders. Normal vs. borderline/abnormal cutoff values
were used.
2.3. EEG recordings
The EEG electrodes were positioned according to the interna-
tional 10–20 system. Every wake EEG recording lasted 30 min and
was performed according to a standard protocol.38 Sleep EEG
recordings were started after lunch and partial sleep deprivation.
The recording was continued to reach phase III and IV slow sleep.
Then, the child was awakened for a 20-min baseline recording
followed by hyperventilation (HP) and intermittent light stimula-
tion (ILS). Background activity, electroclinical events and interictal
discharges were evaluated.
The level of agreement regarding the interpretation of the EEG
recordings by three different experienced readers working in the
participating centers has been found to be satisfactory: Kappa
values for presence of interictal or ictal discharges and for all the
relevant features of the sleep EEG were 0.74-1.38
2.4. Statistical analyses
Statistical analysis was performed using the statistical package
SAS/PC version 6.12 (SAS Institute Inc, Cary, NC). The Student’s t-
test for paired samples and the chi-square test were used to
compare the changes in the test scores at T0 and T1. Multiple and
logistic regressionmodels were also used to assess the inﬂuence of
the demographic, clinical and therapeutic variables (epilepsy
syndrome, age at seizure onset, duration of active epilepsy, ictal
and interictal EEG abnormalities, type of drug, behavioural–
emotional aspects and family socio-cultural level) on the changes
of each test score.
The study was a self-supported independent investigation.
3. Results
3.1. Clinical, behavioural and socio-economic data
The main clinical features in patients with partial and
generalized epilepsy are depicted in Table 1. At diagnosis, seizures
were generalized in 23 patients (53.5%): non-convulsive in 19
patients (44.2%) and convulsive in four (9.3%). Seizures were
partial in eight cases (18.6%) and partial with secondary
generalization in 12 (27.9%).
Before starting antiepileptic therapy, seizures occurred on a
daily basis in 19 cases (44.2%), weekly in one child, andmonthly or
less frequently in 23 patients (53.5%). Seizures appeared while
awake in 30 cases (69.7%), during sleep in seven (16.3%), and on
awakening in six (14%).
After 12 months of therapy (T1), seizures were present in 10
patients (23.3%); 6with partial epilepsy (3 on carbamazepine and 3
on valproate) and 4 with generalized epilepsy (all on valproate).
None of the patients was withdrawn from medication before the
neuropsychological retest at 12 months. No signiﬁcant side effects
were reported by patients or parents after 12 months of therapy.
During EEG recording at diagnosis (T0), 22 patients (51.2%) had
electroclinical paroxysms, which were generalized in 19 (44.2%),
partial in two (4.6%) and secondarily generalized in one (2.3%). We
recorded interictal EEG abnormalities in 35 patients (81.4%). After
12 months (T1), interictal EEG abnormalities were documented in
11 cases (25.6%). A family history of epilepsy was present in ﬁve
cases (11.6%) and a family history of febrile convulsions in three
(7%). The socio-economic and cultural level was high in ﬁve
children (11.6%), medium in 30 (69.8%) and low in eight (18.6%).
At T0, behavioural and emotional problems were present in 14
cases (32.6%), as stated by parents through the CBCL. Behavioural
Table 1
General characteristics of the sample by epilepsy syndrome.
Generalized epilepsy Partial epilepsy Total
N (%) 23 (53.5) 20 (46.5) 43 (100)
N (%) absence epilepsy 19 (44.2) – 19 (44.2)
N (%) frontal epilepsy – 5 (11.6) 5 (11.6)
N (%) rolandic epilepsy – 10 (23.3) 10 (23.3)
N (%) occipital epilepsy – 5 (11.6) 5 (11.6)
N (%) T–C, myoclonic epilepsy 4 (9.3) – 4 (9.3)
Mean age at onset of seizures (SD) 9.9 years (3.4) 9.5 years (3.2) 9.7 years (3.3)
N (%) with onset before age 10 13 (30.2) 12 (27.9) 25 (58.1)
N (%) with onset after age 10 10 (23.3) 8 (18.6) 18 (41.9)
Mean age at treatment start (SD) 10.7 years (3.0) 10 years (3.2) 10.4 (3.1)
N (%) with AE within 6 monthsa 17b (39.5) 14 (32.6) 31 (72.1)
N (%) with AE after 6 monthsa 6 (13.95) 6 (13.95) 12 (27.9)
N (%) with valproate 23 (53.5) 12 (27.9) 35 (81.4)
N (%) with carbamazepine – 8 (18.6) 8 (18.6)
N (%) with seizure remissions at T1 19 (44.2) 14 (32.5) 33 (76.7)
AE, antiepileptic drugs; SD, standard deviation; T–C, tonic–clonic seizures.
a From onset of seizures.
b Within 2 months in 14 cases, all with absence epilepsy.
Table 3
Neuropsychological proﬁle by socio-economic status and behavioural problems at
T0. Multiple regression and *logistic regression analysis.
Low social level Medium social level High social level TOT
No. of patients 8 30 5 43
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Overall, no signiﬁcant changes were detected in 36 patients during
follow-up, although there was an improvement in three patients
and worsening in four.
3.2. Neuropsychological proﬁle
The neuropsychological proﬁle of the study population at T0
and T1 is summarized in Table 2. The results were compared to the
normative values at T0 and T1 and the scores were considered
abnormal when they were 2 standard deviation (SD) below
normative media values.
One child showed clinically relevant difﬁculties (scores < 2 SD)
in verbal memory and 11 (25.6%) had borderline results (i.e.
between 1 and 2 SD) in executive functions. At the same time, 14
patients (32.6%) showed a speciﬁc attention disorder at CPT (at
least 4 abnormal scores), with long reaction times and a cautious
procedural style. School difﬁculties were reported by the parents
and teachers in ﬁve patients (11.6%) at the onset of epilepsy. One
child required special educational assistance.
After 12 months (T1) all the memory and executive function
parameters showed a marked improvement. The patient with
memory difﬁculties at T0 performedwithin the normal range at T1
and only four of the 11 patients with mild difﬁculties in the
executive functions at T0 were unchanged at T1. In contrast, 23
patients (53.5%) at T1 (compared to 14 at T0) had clinically speciﬁc
attention deﬁcits on CPT (at least 4 abnormal scores). Nevertheless
the increase of patients with speciﬁc attention deﬁcits from T0 toTable 2
Neuropsychological proﬁle at T0 and T1.
Test Mean SD at T0 Mean SD at T1 p
WISC-R full IQ 104.3715.1 103.3915.6 ns
WISC-R verbal IQ 105.0914.6 103.3716.1 ns
WISC-R performance IQ 102.8617.3 103.0615.1 ns
TEMA full IQ 98.5819.8 105.3912.2 0.015
TEMA verbal IQ 99.9515.0 103.4611.3 0.053
TEMA non-verbal IQ 101.6515.2 106.6915.0 0.011
TEMA differed IQ 99.128.6 103.679.3 0.013
WCST % errors 96.1016.2 108.6517.2 0.000
WCST % perseverations 100.7815.3 110.8916.1 0.001
WCST % conceptual level 96.5516.8 107.8115.9 0.000
Test N (%) at T0 N (%) at T1
CPT abnormal 14 (36.2) 23 (53.5) ns
For a description of the tests, see text; SD, standard deviation.T1 was not statistical signiﬁcant (p = 0.66). Most children (85.7%)
presented long reaction times and a cautious procedural style.
3.3. Relationship between the neuropsychological proﬁle and epilepsy
behavioural, socio-cultural and economic features
Multiple and logistic regression analysis failed to document
signiﬁcant correlations between neuropsychological proﬁle (IQ,
attention, memory and executive functions) and most of demo-
graphic, clinical, electrophysiological and therapeutic variables.
Only behavioural–emotional features and socio-cultural levelwere
strongly correlated to the neuropsychological data (p < 0.05). Their
correlation with the neuropsychological scores was assessed
separately at T0 (Table 3) and T1 (Table 4). In contrast, treatment
was associatedwith signiﬁcant changes in some intellectual scores
during the follow-up (Table 5). As shown in Table 3, the presence of
behavioural and emotional difﬁculties at the onset of epilepsy was
associated with intellectual and memory problems; although still
within the limits of normality, these patients had a lower full and
performance IQ, and lower non-verbal and differed memory
abilities. Moreover, patients with an abnormal CBCL proﬁle mostTest Mean SD Mean SD Mean SD p
WISC-R (coding) 74.2 10.83.6 11.61.7 0.007
Abnormal CBCL Normal CBCL TOT
No. of patients 14 29 43
Test Mean SD Mean SD p
WISC-R full IQ 98.811.1 10815.5 0.021
WISC-R Performance IQ 94.69.3 106.819.0 0.029
WISC-R (comprehension) 8.381.8 10.62.3 0.033
WISC-R (images completion) 8.51.5 10.63.4 0.018
TEMA non-verbal IQ 9513.6 104.915.1 0.044
TEMA differed IQ 94.99.6 101.27.4 0.042
Test N (%) N (%) p
Abnormal CPT 8/14 (57.1) 6/29 (20.7) 0.021*
For a description of the tests, see text; only testswith signiﬁcant results are reported
(p<0.05); SD= standard deviation; variables included in the model: epilepsy
syndrome, age at seizure onset, disease duration, ictal EEG abnormalities, CBCL
score at T0 and family socio-cultural level.
Table 4
Neuropsychological proﬁle by socio-economic status and behavioural problems at T1. Multiple regression and *logistic regression analysis.
Low social level Medium social level High social level p
No. of patients 8 30 5 43
Test Mean SD Mean SD Mean SD p
WISC-R full IQ 97.017.5 103.714.6 114.89.4 0.013
WISC-R performance IQ 96.112.6 103.615.6 113.410.3 0.007
WISC-R (history sequences) 10.22.9 10.83.2 11.62.2 0.026
WISC-R (coding) 8.13.7 9.53.0 11.62.2 0.026
TEMA full IQ 99.313.4 105.510.7 113.617.5 0.011
Abnormal CBCL Normal CBCL TOT
No of patients 15 28 43
Test Mean SD Mean SD p
WISC-R full IQ 95.115.2 107.814.1 0.003
WISC-R performance IQ 92.913.0 108.513.4 0.000
WISC –R (images completion) 9.52.5 11.32.6 0.034
WISC-R (histories sequences) 9.73.7 11.82.4 0.017
WISC-R (geometric ﬁgures) 9.52.8 12.32.8 0.003
WISC-R (puzzles) 8.32.6 10.52.4 0.092
TEMA full IQ 97.711.3 109.510.7 0.000
TEMA non-verbal IQ 98.512.6 111.114.5 0.007
TEMA verbal IQ 96.512.7 107.28.7 0.002
Test N (%) N (%) p
Abnormal CPT 14/15 (93.3) 9/28 (32.1) 0.011*
For a description of the tests, see text; only tests with signiﬁcant results are reported (p<0.05); SD= standard deviation; variables included in themodel: epilepsy syndrome,
age at seizure onset, disease duration, interictal EEG abnormalities, drug type, CBCL score at T0 and T1 and family socio-cultural level.
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documented by the CPT test.
The inﬂuence of these two variables becamemore relevant after
12 months (T1) (Table 4). The existence of behavioural and
emotional difﬁculties and the presence of a low socio-cultural and
economic level were strongly associatedwith impairment of the IQ
and memory functions. In addition, 93.3% of patients with
emotional and behavioural impairment on CBCL presented an
attention disorder on CPT.
Drug treatment with carbamazepine, but not with valproate,
was found to mildly affect the IQ (Table 5).
4. Discussion
The principal aim of this work was to study intellectual level,
memory, attention and executive functions in children and
adolescents with newly diagnosed epilepsy (before starting
antiepileptic drugs) and after 1 year of therapy. A second aim
was to identify which among neurological, behavioural,
electrophysiological, therapeutic, social and educational variables
were relevant for neuropsychological outcome. As our intent was
to assess any possible changes of the neuropsychological proﬁle in
a cohort of patients with epilepsy, we decided not to investigate
healthy individuals or other control populations. To deal with a
homogeneous inception cohort, we enrolled only patients who
were consecutively referred to our clinics with newly diagnosed
idiopathic generalized and partial epilepsies. To better evaluate theTable 5
Drug therapy and change of intellectual level from T0 to T1.
T0 T
VPA CBZ V
WISC-R full IQ 103.215.1 109.214.9 1
WISC-R performance IQ 100.416.5 113.717.6 1
WISC-R (images completion) 9.63.0 11.73.1
For a description of the tests, see text; only tests with signiﬁcant results are reported
epilepsy syndrome, age at seizure onset, disease duration, ictal EEG abnormalities, drucorrelation of the patients’ neuropsychological proﬁle with the
disease itself, we excluded symptomatic epilepsies, prevalent
cases and those requiring polytherapy, all factors associated with
cognitive impairment.8,39,40
We found normal intellectual abilities in our patients. However,
at diagnosis, 11% of them had mild educational problems and 25%
had borderline logical and executive abilities. In addition, about
one-third of them presented with speciﬁc attention disorders and
psychological disturbances.
Our data are in line with other reports, which showed cognitive
and behavioural difﬁculties and academic underachievement at
the onset of idiopathic epilepsy.41–43 The nature and timing of
cognitive and behavioural impairment are probably a consequence
of multiple factors, such as the age of epilepsy onset and the
persistence of interictal cortical paroxysms during sleep.9 Some
studies documented cognitive impairment in children and
adolescents with early epilepsy,18,20,41 suggesting the inﬂuence
of an early adverse impact of the disease on cognition. In addition,
in keeping with us other authors14,41,44 reported that (early)
neuropsychological and behavioural deﬁcits were correlated to the
psychosocial and familial context.
Almost one-third of our patients had attention deﬁcits on CPT
and behavioural and emotional problems on CBCL at diagnosis.
Behavioural difﬁculties have been described in about one-fourth of
patients with epilepsy.45–47 Most of our patients with attention
deﬁcit presented behavioural and emotional problems, long
reaction times and a cautious procedural style. Pre-existing1 T0–T1 p
PA CBZ VPA CBZ
04.214.1 100.021.6 +0.91 9.25 0.002
02.613.8 105.121.1 +2.2 8.63 0.012
10.82.7 10.02.9 +1.14 1.7 0.009
(p<0.05); VPA=valproate; CBZ= carbamazepine; variables included in the model:
g type, CBCL score at T0 and family socio-cultural level.
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Oostrom et al.41 Conversely, attention difﬁculties could be
explained by marked ictal cortical activity during sleep, as shown
by Sanchez-Carpintero and Neville.48 This hypothesis could not be
veriﬁed in our sample because not all our patients underwent EEG
recording during sleep.
After 12 months of treatment, the intellectual level in our
sample was as expected virtually unchanged, but speciﬁc
neuropsychological functions, including memory and logical and
executive abilities, showed a signiﬁcant improvement.
Verbal, non-verbal and also deferredmemory abilities appeared
to be improved after 12months of treatment, to the same extent in
patients treatedwith valproic acid and carbamazepine. Bittencourt
et al.49 showed a similar improvement, especially in patients
treated with carbamazepine, while Schouten et al.50 considered
the impact of treatment on memory functions in a pediatric
population to be non-inﬂuential. In our cases, a marked favorable
impact of treatment was also registered on executive functions.
There are no studies on the effects of treatment on executive
functions in children with epilepsy.
At the end of follow-up, a non-signiﬁcant increasewas observed
in the number of cases with speciﬁc attention disorders and the
proportion of children with behavioural disturbances was moder-
ately increased. At T1 attention deﬁcits and behavioural dis-
turbances were more pronounced than at T0.
Chevalier et al.51 suggested that children with epilepsy may be
more impulsivebecause of a less efﬁcient control of inhibitiondue to
frontal lobe dysfunction. In our subjects we can reasonably exclude
this factor as all children improved on WCST and performed quite
well on theWISC-R ‘‘Similarities’’ sub-testwhich taps the logical and
inferential processes of the frontal lobes. Moreover, unlike
Holtmann et al.,52 we did not ﬁnd hyperactive-impulsive (ADHD-
like) conduct butmerely slowness and easy fatigue, which aremore
easily correlatedwith the typical anxiety-depression proﬁle of these
children, as reported in a previous work.47
Remarkably, at T0 and even at the end of follow-up, the only
variables that could explain the evolution of the neuropsycho-
logical proﬁlewere the behavioural and emotional assets on CBCL,
the socio-cultural level and, to a lesser extent, the type of
antiepileptic drug.
The impact of behavioural difﬁculties was extended to the IQ,
with special reference to performance abilities, all memory
components and attention.
Sturniolo and Galletti53 correlated the emotional difﬁculties in
pediatric epilepsy to low school achievements, conﬁrming the
hypothesis of a direct inﬂuence of the emotional asset on
neuropsychological outcome. The socio-cultural grading level
could also partially explain the gradient seen for the intellectual
abilities and global memory functions of our sample. This ﬁnding
could be correlated to a differing environmental motivation and
encouragement toward school and learning. This element could be
considered a protective factor toward neuropsychological devel-
opment in a particularly stressful condition like epilepsy. Our
ﬁndings agree with recent studies, which documented a strong
correlation between psychosocial variables, maladaptive parent-
ing in the earliest months after diagnosis, and behavioural-
cognitive difﬁculties in epileptic children.14,16,19,41,54
Unexpectedly, the patients in our sample who were taking
carbamazepine had a mild deterioration of the intelligence
quotient. Although this ﬁnding can be questioned in light of the
small sample size (8 patients), a possible explanation could be the
preferential use of this drug in partial epilepsy, which may be
associated per se to cognitive impairment. This ﬁnding is still
controversial. Gillham et al.55 and Dodrill and Wilensky56
conﬁrmed the negative impact of carbamazepine on cognitive
functions.The study has four major limitations. First, we did not include
normal controls for comparison. The lack of a healthy control group
would have been valuable not only in identifying subtle cognitive
problems at onset but also in controlling for test–retest practice
effects on the cognitive measures. However, as well as our main
research focus was to outline the cognitive proﬁle of patients with
newly diagnosed epilepsy and detect any possible changes after
the start of drug treatment. Second, the study population is
represented by patients seen in tertiary referral centers. This is a
rather skewed sample, which is unlikely to represent the general
population of children and adolescents with epilepsy. However,
selection bias is perhaps minimized here because included were
only patients with previously untreated epilepsy who, at least in
Italy have the same opportunity to be seen in primary, secondary,
or tertiary institutions. Third, the small sample size prevents us
from drawing ﬁrm conclusions, as many differences perhaps failed
to attain statistical signiﬁcance. This may be even more important
when collapsing continuous variables (e.g. CPT-scores) into
dichotomous variables (normal vs. abnormal), which further
reduces the sensitivity, and consequently the power, of the
measure. However, often the clinical signiﬁcance of a score is
better predicted by a categorical than continuous variable. Fourth,
the use of a high number of tests increases the likelihood of
interpreting chance ﬁndings. However, a large test battery was
required here in order to provide a fairly complete assessment of
the neuropsychological proﬁle of our study population. In this
context, the study of a larger population would have been very
expensive and time-consuming.
In conclusion, behavioural disturbance and psychosocial
context, rather than epilepsy, were correlated to cognitive
difﬁculties in our population. The pre-existing psychological
features, behavioural history and learning abilities of children,
together with the parents’ adaptation to epilepsy and their ability
to continue habitual parenting without excessive anxiety, are
probably relevant risk factors for the onset of behavioural and
cognitive disturbances at baseline and during the course of the
disease. It is crucial to consider these aspects as early as possible in
taking a integrated therapeutic approach.
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